Type 1 Diabetes

Artificial Pancreas Treatment Efficacious for Type 1 Diabetes

April 20, 2018

Increased time in the near normoglycemic range and reduced time in hypo- and hyperglycemia

Sotagliflozin NDA Submitted to FDA for Type 1 Diabetes

By March 26, 2018

Sotagliflozin is an investigational dual sodium-glucose co-transporter types 1 and 2 (SGLT1, SGLT2) inhibitor.

Ozempic, Fiasp Now Available for the Treatment of Diabetes

By February 05, 2018

Both medications received approval from the FDA in 2017.

New Consensus Report Defines Clinically Meaningful T1D Outcomes

By November 22, 2017

To address this issue, the Type 1 Diabetes Outcomes Program was launched to develop consensus definitions for a set of priority outcomes for T1D.

Tool May Help Reduce Driving Mishaps Among T1D Patients

April 24, 2017

Researchers say new checklist can help determine when hypoglycemia should keep patients off the road

Self-Reported Ketone Testing Infrequent in T1D Patients

January 27, 2017

Thirty and 20 percent of participants, respectively, reported never and rarely checking ketones